Drugs / ChAdOx1 Zika
Trials 2
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04440774 | Oct 2020 → Feb 2022 | Zika virus infectious disease, chikungunya | University of Oxford | Completed | No outcome recorded |
| Phase 1 | NCT04015648 | Oct 2019 → Mar 2022 | Zika virus infectious disease | University of Oxford | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ChAdOx1 Zika | “A single dose of 5x10\^9 vp ChAdOx1 Zika” NCT04440774 ↗ |
| Modality | Vaccine | “candidate ChAdOx1 Zika vaccine” NCT04015648 ↗ |
| Route | Intramuscular | “administered intramuscularly” NCT04015648 ↗ |